132 related articles for article (PubMed ID: 2176308)
1. Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems.
Drapeau G; Rouissi N; Nantel F; Rhaleb NE; Tousignant C; Regoli D
Regul Pept; 1990 Nov; 31(2):125-35. PubMed ID: 2176308
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptor.
Dion S; Rouissi N; Nantel F; Jukic D; Rhaleb NE; Tousignant C; Télémaque S; Drapeau G; Regoli D; Naline E
Pharmacology; 1990; 41(4):184-94. PubMed ID: 1964226
[TBL] [Abstract][Full Text] [Related]
3. Selective agonists for substance P and neurokinin receptors.
Drapeau G; D'Orléans-Juste P; Dion S; Rhaleb NE; Rouissi NE; Regoli D
Neuropeptides; 1987 Jul; 10(1):43-54. PubMed ID: 2444902
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin receptors antagonists: old and new.
Jukic D; Rouissi N; Laprise R; Boussougou M; Regoli D
Life Sci; 1991; 49(20):1463-9. PubMed ID: 1719324
[TBL] [Abstract][Full Text] [Related]
5. Selective agonists for receptors of substance P and related neurokinins.
Regoli D; Dion S; Rhaleb NE; Rouissi N; Tousignant C; Jukic D; D'Orleans-Juste P; Drapeau G
Biopolymers; 1989 Jan; 28(1):81-90. PubMed ID: 2470440
[TBL] [Abstract][Full Text] [Related]
6. Specific agonists for neurokinin B receptors.
Drapeau G; d'Orléans-Juste P; Dion S; Rhaleb NE; Regoli D
Eur J Pharmacol; 1987 Apr; 136(3):401-3. PubMed ID: 3038572
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological receptors for substance P and neurokinins.
Regoli D; Drapeau G; Dion S; D'Orléans-Juste P
Life Sci; 1987 Jan; 40(2):109-17. PubMed ID: 2432376
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system.
Couture R; Laneuville O; Guimond C; Drapeau G; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):547-57. PubMed ID: 2482449
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
10. Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action.
Jacques L; Couture R; Drapeau G; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):170-9. PubMed ID: 2478892
[TBL] [Abstract][Full Text] [Related]
11. Characterization of neurokinin receptors in various isolated organs by the use of selective agonists.
Dion S; D'Orléans-Juste P; Drapeau G; Rhaleb NE; Rouissi N; Tousignant C; Regoli D
Life Sci; 1987 Nov; 41(20):2269-78. PubMed ID: 2824947
[TBL] [Abstract][Full Text] [Related]
12. Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed.
D'Orléans-Juste P; Claing A; Télémaque S; Warner TD; Regoli D
Eur J Pharmacol; 1991 Nov; 204(3):329-34. PubMed ID: 1723050
[TBL] [Abstract][Full Text] [Related]
13. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.
Maggi CA; Patacchini R; Giuliani S; Rovero P; Dion S; Regoli D; Giachetti A; Meli A
Br J Pharmacol; 1990 Jul; 100(3):589-92. PubMed ID: 2167737
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi.
Naline E; Devillier P; Drapeau G; Toty L; Bakdach H; Regoli D; Advenier C
Am Rev Respir Dis; 1989 Sep; 140(3):679-86. PubMed ID: 2476956
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
16. Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonist.
Tousignant C; Chrétien L; Guillemette G; Regoli D
Brain Res; 1992 Nov; 596(1-2):243-50. PubMed ID: 1281744
[TBL] [Abstract][Full Text] [Related]
17. Two NK-3 receptor subtypes: demonstration by biological and binding assays.
Nguyen QT; Jukic D; Chrétien L; Gobeil F; Boussougou M; Regoli D
Neuropeptides; 1994 Sep; 27(3):157-61. PubMed ID: 7529376
[TBL] [Abstract][Full Text] [Related]
18. The rabbit jugular vein is a contractile NK-1 receptor system.
Nantel F; Rouissi N; Rhaleb NE; Dion S; Drapeau G; Regoli D
Eur J Pharmacol; 1990 Apr; 179(3):457-62. PubMed ID: 2163859
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies of bradykinin and related peptides. B2-receptor antagonists.
Rhaleb NE; Télémaque S; Rouissi N; Dion S; Jukic D; Drapeau G; Regoli D
Hypertension; 1991 Jan; 17(1):107-15. PubMed ID: 1846119
[TBL] [Abstract][Full Text] [Related]
20. Effects of tachykinins on myenteric neurones of the guinea-pig gastric corpus: involvement of NK-3 receptors.
Schemann M; Kayser H
Pflugers Arch; 1991 Dec; 419(6):566-71. PubMed ID: 1724075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
